Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Novartis to Start Large, Randomized Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients

by Global Biodefense Staff April 20, 2020, 9:58 am
IDEXX Makes Test for COVID-19 Available to Veterinarians Amid Rare Cases of Human-to-Pet Transmission

by Global Biodefense Staff April 20, 2020, 9:47 am
Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients

by Global Biodefense Staff April 20, 2020, 8:55 am
BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2

by Global Biodefense Staff April 17, 2020, 6:37 pm
BARDA and Sanofi Prepare for Studies of COVID-19 Vaccine

by Global Biodefense Staff April 17, 2020, 6:00 pm
FDA Accepts for Priority Review for REGN-EB3 to Treat Ebola

by Global Biodefense Staff April 16, 2020, 4:03 pm
Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets

by Global Biodefense Staff April 15, 2020, 3:58 pm
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients

by Global Biodefense Staff April 14, 2020, 5:09 pm
BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19

by Global Biodefense Staff April 14, 2020, 3:50 pm
Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19

by Global Biodefense Staff April 14, 2020, 3:00 pm
BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections

by Global Biodefense Staff April 13, 2020, 5:00 pm
Lilly Begins Clinical Testing of Therapies for COVID-19

by Global Biodefense Staff April 11, 2020, 3:18 pm
Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College

by Global Biodefense Staff April 10, 2020, 8:02 pm
DuPont to Produce up to 4.5 Million TYVEK Protective Suits for U.S. Healthcare Workers

by Global Biodefense Staff April 9, 2020, 9:12 am

Congratulations. You've reached the end of the internet.

Archives: Newswire

Novartis to Start Large, Randomized Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients

IDEXX Makes Test for COVID-19 Available to Veterinarians Amid Rare Cases of Human-to-Pet Transmission

Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients

BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2

BARDA and Sanofi Prepare for Studies of COVID-19 Vaccine

FDA Accepts for Priority Review for REGN-EB3 to Treat Ebola

Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets

BARDA Facilitates Development of Immunotherapies for COVID-19 Patients

BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19

Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19

BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections

Lilly Begins Clinical Testing of Therapies for COVID-19

Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College

DuPont to Produce up to 4.5 Million TYVEK Protective Suits for U.S. Healthcare Workers

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest Articles